AzTrials
AzTrials

GingivitisNCT02271815

A Clinical and Imaging Study to Evaluate a Novel Dentifrice

An observational study of Gingivitis and Periodontitis, run by University of California, Irvine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is a need for toothpastes that more effectively remove oral biofilm, inhibit biofilm re-formation and support periodontal health. This is particularly important for patients with long-term orthodontic fixtures or prosthodontic appliances, and also for debilitated, diabetic and immunocompromised patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gingivitis, Periodontitis, Dental Plaque
What is being tested?
Oral Hygiene
Type of treatment
Pill or oral medicine
How many people
194 participants
Where
1 siteUnited States
Study dates
Oct 2014to Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Study population will be recruited from University of California Irvine faculty, staff and students as well as individuals residing or working in the UCI neighborhood.

Who may be able to join

  • Male or female over the age of 18
  • Have a previously diagnosed condition of gingivitis and periodontitis including gingival bleeding, gingival inflammation, plaque, and for some study sections at least four sites with probing pocket depths > 4mm.
  • Not pregnant and not lactating.

Who cannot join

  • Participated in other clinical study within the last 30 days.
  • Plan to receive dental treatment during the study dates.
  • History of significant adverse effects following use of oral hygiene products such as toothpastes and mouth rinses.
  • Allergies to personal care/consumer products or their ingredients.
  • Less than 20 teeth (excluding third molars).
  • For some studies, within six months prior to baseline, any quadrant or maintenance S/RP, and/or periodontal surgical therapy
Show all 12Show fewer
  • Diagnosed with active acquired immunodeficiency syndrome (AIDS) or Hepatitis B/C and other significant disease or disorder.
  • Poorly controlled diabetes
  • History of herpetic infection, recurrent aphthous ulcer, or other ulcerative diseases, abscesses, granulomas.
  • History of or currently undergoing immunosuppression
  • Taken antibiotics in the previous 3 months.
  • Taking anti-inflammatory medications or Immunosuppressants.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Beckman Laser Institute, University of california, Irvine

    Irvine, California, 92612

Other trials in United States

About this study

There is a need for toothpastes that more effectively remove oral biofilm, inhibit biofilm re-formation and support periodontal health. This is particularly important for patients with long-term orthodontic fixtures or prosthodontic appliances, and also for debilitated, diabetic and immunocompromised patients. The objective of this study is to evaluate the effects of toothpastes on plaque presence and removal, gingival and periodontal health, dental hard tissue mineralization, erosion, abrasion, and microstructure as well as dry/sore mouth. In addition to clinical scoring and photographs, tooth and gum sensitivity, saliva volume, pH and buffering and enamel health may be evaluated using tooth samples worn on removable dental retainers. These samples will be examined outside of the mouth using advanced optical techniques such as Optical Coherence Tomography (OCT), Fluorescence, various forms of microscopy and spectroscopy.

Read the detailed description

The objective of this study is to evaluate the in vivo effects of toothpastes and dental gels on gingival and periodontal health, enamel demineralization, remineralization and microstructure . The purpose of this study is to evaluate the effects of over-the-counter toothpastes and dental gels including Colgate Total, Crest Cavity Protection, Zendium Classic toothpaste, and Livionex LivFree and LivFresh using established clinical evaluation parameters as well as innovative imaging approaches (Optical Coherence Tomography and Multiphoton Microscopy) to measure the status of the oral tissues

Imaging devices:

  • Optical Coherence Tomography can be used to identify and measure inflammation of the gums and gum pockets.The results can be used to evaluate the health of the gums, and changes caused by using specific toothpastes
  • Multiphoton Microscopy can be used to identify and measure bacterial plaque or biofilm in the mouth. The results can determine effects of specific toothpastes on the development and breakup of bacterial biofilm or plaque.

In the first part of this study, subjects with moderate gingival inflammation (Löe and Silness Gingival Index ≥2) and pocket depths <4 will be randomly assigned to brush twice daily for 21 days with the test or the control dental gel. On Days 0, 7, 14, and 21, plaque levels (Quigley-Hein, Turesky Modification Plaque Index), gingival inflammation (Löe and Silness Gingival Index), and gingival bleeding (modified Sulcus Bleeding Index) will be determined by one blinded, investigator (Dr. Wilder-Smith) using standard probing techniques. In vivo Optical Coherence Tomography (OCT) and Multiphoton Microscopy (MPM) will be used for in situ imaging. The results from this study will help evaluate the effects of the test dentifrice formulation on plaque removal and maintaining gingival health.

In the second part of this study, plaque formation and removal will be quantified in subjects using ex vivo Optical Coherence Tomography (OCT) and Multiphoton Microscopy (MPM) imaging of small enamel chips mounted on a simple intra-oral retainer. In this cross-over design study, the subjects will attend the test site on 11 occasions over an 11-week period. Subjects will have an intra-oral retainer manufactured, which will be worn for a minimum of 22 hours per day and will have up to 8 sterile human enamel inserts fitted.This study will be conducted in three arms with a maximum of 44h of retainer wear during each arm, and each study arm will follow the same procedure. 2 different over-the-counter toothpastes and a water control will be used for each arm of the study, respectively. There will be a minimum of two weeks between each study arm.

The third part of this study will involve subjects with no specific oral health issues. The protocol will involve subjects wearing simple retainers for 3 periods of 2 weeks each with 5 sterilized enamel chips attached in the palate area. The study will have 3 arms using a control and 2 active toothpastes. There will be washout of 1-2 weeks between each study arm. Samples will be analyzed outside of the mouth using OCT and MPM techniques, as well as micro computer tomography (microCT), Energy Dispersive Spectroscopy (EDS) and X-Ray Photoelectron Spectroscopy (XPS). (Section 3 has been completed as of July 11, 2016)

The fourth part of this study will involve subjects with xerostomia. Subjects will wear simple removable retainers for 2 periods of 1 week each, with 5 sterilized demineralized enamel chips attached in the palate area of the retainer. Fresh enamel chips will be used for each arm of the study. After study completion, chips will be used for Scanning Electron microscopy (SEM) and microhardness measurement. We will provide custom retainers made from impressions of each subject. Upon conclusion of the study, we will analyze the effects of each toothpaste on surface enamel using scanning electron microscopy (SEM) and microhardness as well as microCT, EDS and XPS data.

In the fifth part of this study, plaque formation and removal in subjects will be quantified using the standard clinical index for plaque levels (Quigley-Hein, Turesky Modification Plaque Index). This will be determined by one blinded investigator using a periodontal probe. In addition, ex vivo Optical Coherence Tomography (OCT) and Multiphoton Microscopy (MPM) imaging of biofilm samples will be performed on plaque specimens collected using standardized technique and a 2mm curette. In this 3-arm cross-over double-blinded study, the subjects will attend the test site for up to 7 occasions over up to a 22-day period.

The sixth part of this study will involve (a) subjects with previously diagnosed gingivitis, including moderate gingival inflammation (Löe and Silness Gingival Index ≥2) and pocket depths <4, and (b) subjects with previously diagnosed gingivitis (moderate gingival inflammation (Löe and Silness Gingival Index ≥2)) AND periodontitis including gingival bleeding, gingival inflammation, and at least four sites with probing pocket depths >4mm. Subjects will be randomly assigned to brush twice daily for up to 6 months with the test or the control dental gel. On Days 0, 30, 90, and 180, plaque levels (Quigley-Hein, Turesky Modification Plaque Index), gingival inflammation (Löe and Silness Gingival Index), gingival bleeding (modified Sulcus Bleeding Index) and periodontal pocket depths will be determined by one blinded, investigator (Dr. Wilder-Smith) using a periodontal probe. In vivo Optical Coherence Tomography (OCT) and Multiphoton Microscopy (MPM) may be used for in situ imaging if gingival/periodontitis sites are accessible to the imaging probes. The results from this study will help evaluate the effects of the test dentifrice formulation on plaque removal and maintaining/recovering gingival/periodontal health.

Being tested
Oral Hygiene
Keywords
toothpaste, dental gel, dentifrice, plaque removal, oral biofilm, plaque accumulation
Medical subject headings
Gingivitis, Periodontitis, Dental Plaque

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral HygieneOther

    Oral Hygiene

Study groups in NCT02271815
Study groupRoleWhat they receive
Oral HygieneOral Hygiene
Receives: Other: Oral Hygiene

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gingival health measure 1

    Gingival Index

    Measured: Up to 6 months

  2. Gingival health measure 2

    Sulcus Bleeding Index

    Measured: Up to 6 months

  3. Gingival health measure 3

    Optical Coherence Tomography

    Measured: Up to 6 months

  4. Periodontal health measure 1

    Optical Coherence Tomography

    Measured: Up to 6 months

  5. Periodontal health measure 2

    Periodontal Pocket Depths

    Measured: Up to 6 months

  6. Plaque removal and reaccumulation measure 1

    Plaque Index

    Measured: Up to 6 months

  7. Plaque removal and reaccumulation measure 2

    Optical Coherence Tomography

    Measured: Up to 6 months

  8. Plaque removal and reaccumulation measure 3

    Multiphoton microscopy

    Measured: Up to 6 months

Secondary outcomes (6)
  1. Plaque characterization

    Multiphoton microscopy

    Measured: Up to 6 months

  2. Enamel health measure 1

    SEM

    Measured: Up to 6 months

  3. Enamel health measure 2

    microhardness

    Measured: Up to 6 months

  4. Enamel health measure 3

    microCT

    Measured: Up to 6 months

  5. Enamel health measure 4

    EDS

    Measured: Up to 6 months

  6. Enamel health measure 5

    XPS

    Measured: Up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionJun 2021
  4. Study completionJun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
194 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02271815
Sponsor's protocol ID
20139778
Other IDs
Livionex, Inc.
Status last verified
Sep 2022
First submitted
9 Oct 2014
Last updated
15 Sep 2022
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gingivitis and Periodontitis, run by University of California, Irvine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gingival health measure 1 (time frame: Up to 6 months). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in